BioSpace News Archive

ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that it received Health Canada approval of its PXP® System for point-of-care harvesting of purified mononuclear cells and platelets from blood or bone marrow.

Clementia’s late-stage drug candidate, palovarotene, has rare pediatric disease and breakthrough therapy designations for the treatment of an ultra-rare bone disorder and a path to approval in 2020

Masimo announced the findings of a series of four clinical cases, recently published in the Canadian Journal of Anesthesiology, in which researchers at the University of Montreal found that combined use of Masimo SedLine® brain function monitoring and O3® regional oximetry assisted their understanding and management of cerebral desaturations during cardiac surgery.

Athletes are checking out SynTech Nutrition’s all-in-one pre-workout supplement.

The shareholders of BioInvent International AB Reg. No. 556537-7263, are hereby invited to attend the Extraordinary General Meeting (the “EGM”) to be held at 10:00 a.m., Wednesday 20 March 2019 at Elite Hotel Ideon, Scheelevägen 27 in Lund, Sweden.

Reon Revive is a sugar-free, zero-calorie alternative to energy drinks for staying energized on the go or giving you a boost in-between activities.

GeoProtein plans to expand sales of its GeoProtein bar throughout the United States in 2019.

Themis Bioscience announced that the United States Food and Drug Administration has granted fast track designation to the Company’s lead vaccine candidate for the prevention of Chikungunya, a debilitating disease with global outbreak potential.

Coverage will now include Medicare in 38 states and 19 Blue Cross Blue Shield plans

CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will participate in a fireside chat to discuss the company at the 8th Annual SVB Leerink Global Healthcare Conference this Wednesday, February 27, 2019 at 10:00AM EST in New York City.